These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35020481)

  • 41. [Incidence, clinical characteristic and evolution of Clostridioides difficile infection].
    Jorge L; Azula N; Smayevsky J; Herrera F; Temporiti E; Bonvehí P
    Medicina (B Aires); 2021; 81(6):931-938. PubMed ID: 34875590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile infections before and during use of ultraviolet disinfection.
    Nagaraja A; Visintainer P; Haas JP; Menz J; Wormser GP; Montecalvo MA
    Am J Infect Control; 2015 Sep; 43(9):940-5. PubMed ID: 26159499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hospital resource endowments and nosocomial infections: longitudinal evidence from the English National Health Service on Clostridioides difficile between 2011 and 2019.
    Stead S; Vogt L; Antons D; Salge TO; Gecht J; Klasen M; Sopka S
    J Hosp Infect; 2023 Apr; 134():129-137. PubMed ID: 36750139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
    Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
    BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.
    Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P
    World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
    Adams DJ; Barone JB; Nylund CM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium difficile infection incidence: impact of audit and feedback programme to improve room cleaning.
    Smith A; Taggart LR; Lebovic G; Zeynalova N; Khan A; Muller MP
    J Hosp Infect; 2016 Feb; 92(2):161-6. PubMed ID: 26679727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Examining the association between hospital-onset Clostridium difficile infection and multiple-bed room exposure: a case-control study.
    Vaisman A; Jula M; Wagner J; Winston LG
    Infect Control Hosp Epidemiol; 2018 Sep; 39(9):1068-1073. PubMed ID: 30060776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.
    Turner NA; Grambow SC; Woods CW; Fowler VG; Moehring RW; Anderson DJ; Lewis SS
    JAMA Netw Open; 2019 Oct; 2(10):e1914149. PubMed ID: 31664443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
    Johnson SW; Brown SV; Priest DH
    Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "The Invisible Staff": A Qualitative Analysis of Environmental Service Workers' Perceptions of the VA Clostridium difficile Prevention Bundle Using a Human Factors Engineering Approach.
    Yanke E; Moriarty H; Carayon P; Safdar N
    J Patient Saf; 2021 Dec; 17(8):e806-e814. PubMed ID: 29894437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential causal effect of contact precautions and isolation on Clostridioides difficile infection in the hyperendemic setting: Interrupted time-series analyses before and after implementation.
    Lee EH; Lee HS; Lee KH; Song YG; Han SH
    J Microbiol Immunol Infect; 2023 Oct; 56(5):1054-1063. PubMed ID: 37380552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
    Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
    J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.
    van Beurden YH; Dekkers OM; Bomers MK; Kaiser AM; van Houdt R; Knetsch CW; Girbes AR; Mulder CJ; Vandenbroucke-Grauls CM
    PLoS One; 2016; 11(8):e0160778. PubMed ID: 27533048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?
    Lavan AH; McCartan DP; Downes MM; Hill AD; Fitzpatrick F
    Ir J Med Sci; 2012 Sep; 181(3):315-20. PubMed ID: 22350440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temporal change of risk factors in hospital-acquired
    Song J; Cohen B; Zachariah P; Liu J; Larson EL
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1048-1057. PubMed ID: 32468975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reductions in Methicillin-resistant Staphylococcus aureus, Clostridium difficile Infection and Intensive Care Unit-Acquired Bloodstream Infection Across the United Kingdom Following Implementation of a National Infection Control Campaign.
    Edgeworth JD; Batra R; Wulff J; Harrison D
    Clin Infect Dis; 2020 Jun; 70(12):2530-2540. PubMed ID: 31504311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.
    de Blank P; Zaoutis T; Fisher B; Troxel A; Kim J; Aplenc R
    J Pediatr; 2013 Sep; 163(3):699-705.e1. PubMed ID: 23477996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.